When Antibiotics Fail: A Father’s Tragic Story and the Global AMR Crisis
A father recounts his son's battle with antibiotic-resistant infections, highlighting the global threat of antimicrobial resistance and emerging treatments l...
POLICY WIRE — Bekasi, Indonesia — Dr. Felix Liauw recalls the moment he first held his son, Obelix, describing him as their ‘little miracle.’ The pediatrician, now 40, shared the heartbreaking journey of his child’s struggle with a rare condition that ultimately led to his death at just three months old.
After years of trying to conceive, Liauw and his wife were overjoyed by the arrival of their firstborn. However, their joy quickly turned to worry as Obelix faced severe health challenges, including vomiting and diarrhea after every feeding. Despite efforts to adjust their diet and seek medical help, his condition worsened, leading to hospitalization and a series of diagnoses, including congenital short bowel syndrome.
Obelix’s fight against infection continued, but antibiotics proved ineffective, and he eventually succumbed to sepsis in February 2020. His parents believe antimicrobial resistance played a role in his death. The World Health Organization warns that AMR is one of the most pressing global health threats, with millions of deaths linked to drug-resistant infections each year.
📄 POLICY WIRE WHITEPAPER PUBLISHED: PAKISTAN’S NATIONAL SECURITY POLICY PRIORITIES
Meanwhile, in Los Angeles, Mallory Smith, who lived with cystic fibrosis, died at 25 from an infection that antibiotics could not treat. Her mother, Diane Shader Smith, has since become an advocate for awareness about AMR and the potential of bacteriophage therapy, an experimental treatment that targets superbugs using viruses.
Experts warn that AMR is spreading rapidly, driven by overuse in both human medicine and agriculture. While some countries have taken steps to limit antibiotic use in farming, others continue to allow it, contributing to the rise of resistant bacteria. Researchers emphasize the need for better diagnostics, education, and investment in new treatments to combat this growing crisis.
Reporting by Policy-Wire (PW)





